MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE

Mylan Pharmaceuticals ULC🇨🇦 Health Canada

Approval Id: 752c431964b407c0
Drug Approval Canada Name: MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Product Name: MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Status: Marketed
Status Date: 2017-07-31
Original Market Date: 2017-07-31
Din: 02461412
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.08.16
Atc Original: J05AR06 EMTRICITABINE, TENOFOVIR DISOPROXIL AND EFAVIRENZ
Atc Name: j 05 ar 06
Aig Number: 0352327001
Company Name: Mylan Pharmaceuticals ULC
Company Address: 85 Advance Road, Etobicoke, Ontario, Canada, M8Z 2S6

EFAVIRENZ

600 MG

TENOFOVIR DISOPROXIL FUMARATE

300 MG

EMTRICITABINE

200 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

752c431964b407c0

Type

Standard